Will springtime be booster time -- again? Many experts agree that it could be premature to start giving most adults a booster shot on top of the one already offered.
is 91% effective, at first, at preventing hospitalizations. But that drops to 78% at months 4 to 5."Nonetheless, the level of 78 [%] is still a good protective area," Fauci said. "The future requirement for an additional boost, or a fourth shot for mRNA or a third shot for [Johnson & Johnson], is being very carefully monitored in real time," he said, adding that recommendations will be updated as needed.
"At this time, CDC does not have a recommendation for a fourth dose/second booster dose for most Americans," says Scott Pauley, a CDC spokesperson., which has not been peer-reviewed, released this this week, researchers from Sheba Medical Center in Israel followed 274 health care workers after a fourth dose of either the Moderna or the Pfizer vaccine. They found the second booster restored antibody levels to the same peak levels after the third dose but was not good at preventing mild or asymptomatic Omicron infections. Breakthrough infections were common. The researchers said their results suggest the need for ''next-generation vaccine development."Decisions about second booster shots demand that we look at the big picture, says William Schaffner, MD, an infectious disease specialist at Vanderbilt University Medical Center in Nashville. At the moment, he says, hospitalizations are down, and ''even deaths, a lagging indicator,'' are declining, although not to the same degree in all parts of the country. Even so, he says, the trends are going in the right direction. At the White House briefing Wednesday, CDC director Rochelle Walensky, MD, said federal officials are ''cautiously optimistic about the trajectory we are on," noting that the current 7-day daily average of cases is about 147,000, down about 40% from the previous week. Hospital admissions, at 9,500 a day, have declined about 28%, and the 7-day average of daily deaths is about 2,200, a decrease of about 9% from the prior week.from that infection, along with vaccination, will produce a sustained drop in cases."If that is the case, we don't need a booster anytime soon."Then, ''as we move fromto endemic, we will be able to determine at what interval a booster will be necessary and what the composition [of it] will be," Schaffner says. But for now,"I don't think a fourth dose -- a second booster -- is in the cards in the near-term future [for those not immunocompromised], if everything goes the way it has been going."It's hard to give final answers about boosters for the general population without sufficient data yet, agrees Alejandro Balazs, PhD, a virologist and principal investigator at the Ragon Institute of Massachusetts General Hospital, MIT, and Harvard.Amesh Adalja, MD, an infectious disease expert and senior scholar at the Johns Hopkins Center for Health Security, agrees:"If the goal is protection against serious disease, hospitalization, and death, targeting the boosting of high-risk populations [but not others] makes sense as the standard regimens are holding up in the general population." Even as antibody levels decline after vaccinations, your memory T-cell and B-cell response may endure, making it possible to fight the virus, Balazs says."The antibodies can prevent the infection from establishing itself."Despite the lack of data, doctors say their patients are asking now about second boosters. "At this point in time, it is impossible to predict whether additional booster doses will be needed for healthy people,'' says Aaron Glatt, MD, chief of infectious diseases at Mount Sinai South Nassau in Oceanside, NY. Could premature boosting by healthy people have a downside?"I don't see any immediate harm [to that]. However, I'm not so sure about the benefit,” Schaffner says. "The one harm is hypothetical," Adalja says,"and it is that continuing to boost with first-generation vaccines directed against the ancestral strain of the virus may blunt the ability of the: “Three, four or more: what’s the magic number for booster shots?”MedRxiv: “4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC.” William Schaffner, MD, infectious disease specialist, Vanderbilt University Medical Center, Nashville.News briefing, White House COVID-19 Response Team, Feb. 16, 2022. Alejandro Balazs, PhD, virologist and principal investigator, Ragon Institute of Massachusetts General Hospital, MIT, and Harvard. Amesh Adalja, MD, infectious disease expert, senior scholar, Johns Hopkins Center for Health Security, Baltimore.© 2022 WebMD, LLC. All rights reserved.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New back-to-work deal requires boosters for vaccinated film crewsHollywood studios and unions have extended and updated pandemic workplace safety guidelines for movie and TV productions that will require vaccinated cast and crews to show they’ve received COVID-19 booster shots.
Read more »
San Jose delays COVID booster mandate after employees fail to comply“Our goal is really not to discipline employees,” said the city’s HR director.
Read more »
What pregnant people need to know about the COVID boosterIs there a best trimester to get it? Does it matter which shot you get? Is it OK to wait to get the booster until after the baby is born? Dr. TaliBogler, founder of the Pandemic Pregnancy Guide, answers these questions and more.
Read more »
More COVID-19 rules fall as CDC hints at better times aheadThe nation’s top health official says the U.S. is moving closer to the point that COVID-19 is no longer a “constant crisis.”
Read more »
Here's How Long Your COVID Booster Provides ProtectionAccording to a new study, COVID-19 booster shots start to lose effectiveness after four months but still provide protection.
Read more »
Covid-19: Four more Covid-related deaths and 433 in hospitalThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,170.
Read more »